Pyxis Oncology PYXS
NASDAQ PYXS
$1.68 -0.03 (-1.75%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pyxis Oncology (PYXS) Cost of Revenue (2024 - 2025)

Updated

Pyxis Oncology (PYXS) recorded Cost of Revenue of $2.39 million in Q4 2025.

Analysis

Pyxis Oncology (PYXS) Cost of Revenue (2024 - 2025) Analysis & Trends

  • Across earlier years, Cost of Revenue came in at $475,000 in FY2024.
  • The Q4 2025 figure is the lowest quarterly Cost of Revenue since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Pyxis Oncology 106.57 Mn -158.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.39 Mn
Mar 31, 2024 475,000.00
API Access

Pyxis Oncology Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PYXS&period=max&api_key=YOUR_API_KEY